The Promising Pathway Act proposes a novel, conditional pathway to FDA approval. This provision would enable expedited access to pioneering experimental treatments, should you wish to explore such options—it is purely voluntary to utilize these treatments. Furthermore, it sets up a comprehensive tracking system for all patients who opt for these treatments, furnishing real-time data about these new drugs, their potential combinations with approved treatments, and more. This valuable insight equips your physician to make a more informed decision about the optimal treatment plan tailored to your needs.

 

We urge you to voice your support by reaching out to your congressional representatives. To facilitate this, we've made the process swift and straightforward. Click HERE to get started. We also encourage you to spread the word and urge your friends to send these emails too!